Investing Profile

Adam Goulburn

InvestorVCFounder
Founder and Managing Partner at Dimension Capital
dimensioncap.comNew York, New York
Photo of Adam Goulburn, Managing Partner at Dimension Capital
Your Intro Paths to Adam Goulburn

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Adam is a member of
University of New South Wales Network
14 CONNECTIONS
Monash University Network
13 CONNECTIONS

Find Adam Goulburn on

cb
Current Investing Position
Dimension Capital Managing Partner
Investment Range
$1M - $3.0M
Sweet Spot
$2.0M
Investments On Record
21
Current Fund Size
$350M

Adam Goulburn is on these Sector & Stage Rankings

Adam Goulburn's Investments On Record (13)

CompanyStageDateRound SizeTotal Raised
Eikon Therapeutics
Series DFeb 2025$350M
Series BJan 2022$520M
Series AMay 2021$150M
SeedJan 2019
$1B
Co-investors: Josh Wolfe (Lux Capital), Larry Lasky (The Column Group), Leon Chen (The Column Group), Dror Berman (Innovation Endeavors), Eric Schmidt (Innovation Endeavors)
Kaleidoscope
SeedSep 2022$6M
$22M
Co-investors: Jeff Hinck (Rally Ventures), Justin Kaufenberg (Rally Ventures), Pablo Lubroth (Hummingbird Ventures), Nitesh Banta (Stellar Capital), Daren Cotter
Rivet
Series BJun 2022$21M
Series AMar 2020$8M
$33M
Co-investors: Jackson Moses (Afore Capital), Croom Beatty (Menlo Ventures), Chad Packard (Pelion Venture Partners), Newth Morris (Ankona Capital), Andreas Klinger (Prototype Capital), Gale Wilkinson (Vitalize Venture Group), Steven Miller (Origin Ventures), Renata Quintini (Renegade Partners)
Plexium
Series BFeb 2022$100M
Series AJan 2021$35M
$140M
Co-investors: Kiersten Stead (DCVC (Data Collective)), Rob Hopfner (Pivotal bioVenture Partners), Tim Kutzkey (The Column Group)
Gandeeva Therapeutics
Series AJan 2022$40M
$40M
Science 37
Post Ipo EquityOct 2021$200M
Series UnknownAug 2020$40M
$240M
AllStripes
Series BAug 2021$50M
Series AApr 2020$14M
SeedAug 2018$3M
$67M
Co-investors: Nabeel Hyatt (Spark Capital), Deena Shakir (Lux Capital), Nikhil Basu Trivedi (Footwork), Peter Bordes (Trajectory Ventures), Alice Zhang
Adimab
Series UnknownJan 2020
$41M
Co-investors: Carl Gordon (OrbiMed), Terry McGuire (Polaris Partners), Bill Maris (Section 32)

Adam Goulburn's Experience

Co-Founder Dimension2022 - Present
Venture Partner Lux Capital2022 - 2022
Partner Lux Capital2015 - 2022
Founding CEO VNV Bio (now Aera Therapeutics)2018 - 2021
Principal Lux Capital2014 - 2015
Founding CEO Kallyope2014 - 2015
Senior Associate Lux Capital2012 - 2014
Associate Lux Capital2011 - 2012
Post-Doctoral Associate Weill Cornell Medical College2010 - 2011

Adam Goulburn's Education

Monash University PhD Stem Cell Research
University of New South Wales Bachelor of Commerce / Bachelor of Science International Business, Accounting, Biotechnology